T cells have been implicated in the loss of myelin in monkeys with a central nervous system (CNS) disease that is similar to multiple sclerosis (MS) in humans, providing hope that antivirals could be developed as a potential MS treatment. Conducted by a team from Oregon Health and Science University (OSHU; Portland, OR, USA) and published in the Annals of Clinical and Translational Neurology, the study aimed to probe further into the chance discovery of a naturally occurring disease called Japanese macaque encephalomyelitis in a group of Japanese macaques at the Oregon National Primate Research Center in 2011. If the cause and progression of the...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!